Aspira Pathlab & Diagnostics Limited (BOM:540788)
90.05
-1.80 (-1.96%)
At close: Aug 21, 2026
BOM:540788 Revenue
Aspira Pathlab & Diagnostics had revenue of 62.89M INR in the quarter ending June 30, 2026, with 19.83% growth. This brings the company's revenue in the last twelve months to 260.23M, up 15.09% year-over-year. In the fiscal year ending March 31, 2026, Aspira Pathlab & Diagnostics had annual revenue of 249.82M with 13.56% growth.
Revenue (ttm)
260.23M
Revenue Growth
+15.09%
P/S Ratio
3.58
Revenue / Employee
n/a
Employees
141
Market Cap
926.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 249.82M | 29.83M | 13.56% |
| Mar 31, 2025 | 219.99M | 87.94M | 66.60% |
| Mar 31, 2024 | 132.05M | -12.52M | -8.66% |
| Mar 31, 2023 | 144.57M | -50.85M | -26.02% |
| Mar 31, 2022 | 195.42M | 43.37M | 28.52% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Clinitech Laboratory | 94.91M |